Novartis AG

Common Name
Novartis
Country
Switzerland
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
103,000
Ticker
NOVN
Exchange
SIX SWISS EXCHANGE
Description
Novartis AG is a global healthcare company that operates in the pharmaceuticals and biotechnology sectors. Its primary function is to research, develop, and manufacture healthcare products, with a foc...

Novartis Waste Data Preview

In 2023, Novartis conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2024202320222021 - 2017
Total Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Waste Recovered
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Non-Hazardous Waste Disposed
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.

Insights into Novartis's Waste Treatment Practices

In 2023, Novartis generated a total of 34,900 metric tonnes of waste.

Of this amount, 47.28% of Novartis's total waste generated was recovered through methods such as recycling, reuse, or composting, while 52.72% was disposed of through landfilling, incineration, or combustion.

Novartis's Waste Recovery Rate

47%

How much of Novartis's waste is recycled or recovered?

In 2023, Novartis reported a total waste generation of 34,900 metric tonnes, of which 47.28% was recovered through recycling, reuse, or composting. This moderate level of recovery indicates that Novartis is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.

Has Novartis reduced its environmental waste footprint over time?

Since 2021, Novartis's total waste generation decreased by 26.37%, including a further 21.04% drop in 2023, highlighting a consistent and deliberate reduction in waste production over time.

Over the same period, Novartis's waste recovery rate declined by 16.07%, with a further 12.93% drop in 2023, underscoring a weakening in waste diversion performance and a potential drift away from circular waste strategies.

Overall, while Novartis has successfully reduced its total waste generation, its waste recovery efforts have also declined. This pattern could suggest a shift in strategy away from circular treatment methods or a lag in recovery infrastructure development.

Novartis’s Waste Recovery vs. Disposal Over Time

202120222023015 k30 k45 k60 ktonnes
  • Total Waste Disposed
  • Total Waste Recovered

Insights into Novartis’s Generation of Hazardous and Non-Hazardous Waste

In 2023, Novartis generated a total of 34,900 metric tonnes of waste.

Of this amount, 45.85% of Novartis's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 54.15% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.

Novartis’s Hazardous vs Non-Hazardous Waste Over Time

202120222023015 k30 k45 k60 ktonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How Novartis reduced the environmental impact of its waste?

Since 2021, Novartis's total waste generation decreased by 26.37%, with an additional 21.04% decline in 2023, suggesting a consistent and deliberate effort to minimize waste generation at the source.

Over the same period, Novartis reduced the hazardousness of its waste by 19.81%, with a further 17.96% decline in 2023, suggesting a sustained and meaningful shift toward safer waste profiles and lower environmental impact.

Overall, Novartis has made consistent and substantial progress in reducing both the quantity and the danger of its waste, highlighting a strong, well-executed waste strategy focused on minimizing environmental impact.

How does Novartis treat its hazardous waste?

In 2023, Novartis reported that 16,000 metric tonnes of its total waste output were classified as hazardous. This represents 45.85% of its overall waste generation.

The company treated this hazardous waste using a combination of methods. Approximately 25.62% was managed through recovery methods, indicating a moderate integration of circular practices into its hazardous waste management. However, a significant share was still directed toward disposal, highlighting room for improvement in reducing the long-term impact of hazardous materials.

Breakdown of Novartis's Hazardous and Non-Hazardous Waste by Treatment Method

Hazardous WasteDisposed(34.1%)Hazardous WasteRecovered(11.7%)Non-Hazardous WasteDisposed(18.6%)Non-Hazardous WasteRecovered(35.5%)
Want Full Access to Novartis's Waste Management Dataset?
Sign Up